Buy Or Sell Pfizer Stock?

Let’s dive into details regarding each of the evaluated factors, but first, for quick context: With $143 Bil in market ...

Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026.

Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026. Keep your expectations in check.
BioSpace

Pfizer CEO Blasts HHS’ Anti-Vaccine Policies as Revenue Outlook Dims

Pfizer CEO Albert Bourla defended his company’s vaccine business as rhetoric from HHS Secretary Robert F. Kennedy Jr. drives ...

Pfizer leads COVID-19 vaccine peers lower after revamped guidance

Pfizer (PFE) stock falls, and its COVID vaccine peers such as Moderna (MRNA) and Novavax (NVAX) also drop as the company ...

Is Pfizer A Recovery Opportunity After Covid Vaccine Boom Fades?

If you are wondering whether Pfizer at around $25 a share is a value trap or a genuine opportunity, this breakdown will help you decide whether it deserves a spot on your watchlist right now. Despite ...
Hosted on MSN

Amid Vaccine Controversy, Pfizer Says New Covid Shots Are Effective

Dramatic changes wrought by health secretary Robert F. Kennedy Jr. on vaccine regulation in the U.S. are making this year’s launch of the updated Covid-19 shots the rockiest in years, with sharply ...